Review



bl21 de3  (tiangen biotech co)


Bioz Verified Symbol tiangen biotech co is a verified supplier
Bioz Manufacturer Symbol tiangen biotech co manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    tiangen biotech co bl21 de3
    Bl21 De3, supplied by tiangen biotech co, used in various techniques. Bioz Stars score: 99/100, based on 260 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)/pm42956452-44-5-9
    Average 99 stars, based on 260 article reviews
    bl21 de3 - by Bioz Stars, 2026-11
    99/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: A potential virulence factor: Brucella flagellin FliK does not affect the main biological properties but inhibits the inflammatory response in RAW264.7 cells.
    Article Snippet: The bacterial flagellum is an elongated filament that protrudes from the cell and is responsible for bacterial motility.. It can also be a pathogen-associated molecular pattern (PAMP) that regulates the host immune response and is involved in bacterial pathogenicity.. In contrast to motile bacteria, the Brucella flagellum does not serve a motile purpose.

    Cloning:

    Article Title: Discovery and mechanistic analysis of a novel source protein glutaminase PG5 and its potential application.
    Article Snippet: In this study, we successfully obtained a novel source protein glutaminase PG5 with specific activity of 10.4 U/ mg, good tolerance and broad substrate profile through big data retrieval.. Structural analysis and site-directed mutagenesis revealed that the catalytic pocket of Mature-PG5 contained a large number of aromatic amino acids and hydrophobic amino acids, and that Ser72 greatly affects the properties of the catalytic pocket and the affinity of PG5 for the substrate.. In addition, molecular dynamics analysis revealed that the opening and closing between amino acid residues Gly65 and Thr66 with Cys164 at the catalytic cleft could affect substrate binding and product release.

    Expressing:

    Article Title: Discovery and mechanistic analysis of a novel source protein glutaminase PG5 and its potential application.
    Article Snippet: In this study, we successfully obtained a novel source protein glutaminase PG5 with specific activity of 10.4 U/ mg, good tolerance and broad substrate profile through big data retrieval.. Structural analysis and site-directed mutagenesis revealed that the catalytic pocket of Mature-PG5 contained a large number of aromatic amino acids and hydrophobic amino acids, and that Ser72 greatly affects the properties of the catalytic pocket and the affinity of PG5 for the substrate.. In addition, molecular dynamics analysis revealed that the opening and closing between amino acid residues Gly65 and Thr66 with Cys164 at the catalytic cleft could affect substrate binding and product release.

    Article Title: ZYG11B suppresses multiple enteroviruses by triggering viral VP1 degradation
    Article Snippet: After 24 h, cells were washed with PBS and fixed in 4% paraformaldehyde at 37°C for 10 min, and fluorescence was visualized using an Olympus FV 3000 laser scanning confocal microscope. .. BL21 (DE3, TIANGEN, CB105) competent cells transformed constructs, and protein expression was induced in 3 L of bacterial culture using 0.5 mM IPTG (Sigma-Aldrich, 16758) when OD600 reached 0.6–0.8 overnight at 16°C with shaking at 100 rpm. .. BL21 (DE3, TIANGEN, CB105) competent cells transformed constructs, and protein expression was induced in 3 L of bacterial culture using 0.5 mM IPTG (Sigma-Aldrich, 16758) when OD600 reached 0.6–0.8 overnight at 16°C with shaking at 100 rpm.

    Article Title: ZYG11B suppresses multiple enteroviruses by triggering viral VP1 degradation.
    Article Snippet: .. BL21 (DE3, TIANGEN, CB105) competent cells transformed constructs, and protein expression was induced in 3 L of bacterial culture using 0.5 mM IPTG (Sigma-Aldrich, 16758) when OD600 reached 0.6–0.8 overnight at 16°C with shaking at 100 rpm. ..

    Article Title: Identification and expression profiles of granzyme genes in immune response from Nile tilapia (Oreochromis niloticus)
    Article Snippet: Granzymes (Gzms) are crucial cytotoxic molecules involved in cell-mediated immunity in mammals.. However, their roles in teleost fish, such as Nile tilapia, were less understood.. In this study, we focused on the identification of granzyme genes (OnGzms) from Nile tilapia (Oreochromis niloticus) and the potential functions in antiinfectious immunity, as well as their expression patterns in response to interleukin-2 stimulation.

    Transformation Assay:

    Article Title: ZYG11B suppresses multiple enteroviruses by triggering viral VP1 degradation
    Article Snippet: After 24 h, cells were washed with PBS and fixed in 4% paraformaldehyde at 37°C for 10 min, and fluorescence was visualized using an Olympus FV 3000 laser scanning confocal microscope. .. BL21 (DE3, TIANGEN, CB105) competent cells transformed constructs, and protein expression was induced in 3 L of bacterial culture using 0.5 mM IPTG (Sigma-Aldrich, 16758) when OD600 reached 0.6–0.8 overnight at 16°C with shaking at 100 rpm. .. BL21 (DE3, TIANGEN, CB105) competent cells transformed constructs, and protein expression was induced in 3 L of bacterial culture using 0.5 mM IPTG (Sigma-Aldrich, 16758) when OD600 reached 0.6–0.8 overnight at 16°C with shaking at 100 rpm.

    Article Title: ZYG11B suppresses multiple enteroviruses by triggering viral VP1 degradation.
    Article Snippet: .. BL21 (DE3, TIANGEN, CB105) competent cells transformed constructs, and protein expression was induced in 3 L of bacterial culture using 0.5 mM IPTG (Sigma-Aldrich, 16758) when OD600 reached 0.6–0.8 overnight at 16°C with shaking at 100 rpm. ..

    Article Title: Identification and expression profiles of granzyme genes in immune response from Nile tilapia (Oreochromis niloticus)
    Article Snippet: Granzymes (Gzms) are crucial cytotoxic molecules involved in cell-mediated immunity in mammals.. However, their roles in teleost fish, such as Nile tilapia, were less understood.. In this study, we focused on the identification of granzyme genes (OnGzms) from Nile tilapia (Oreochromis niloticus) and the potential functions in antiinfectious immunity, as well as their expression patterns in response to interleukin-2 stimulation.

    Construct:

    Article Title: ZYG11B suppresses multiple enteroviruses by triggering viral VP1 degradation
    Article Snippet: After 24 h, cells were washed with PBS and fixed in 4% paraformaldehyde at 37°C for 10 min, and fluorescence was visualized using an Olympus FV 3000 laser scanning confocal microscope. .. BL21 (DE3, TIANGEN, CB105) competent cells transformed constructs, and protein expression was induced in 3 L of bacterial culture using 0.5 mM IPTG (Sigma-Aldrich, 16758) when OD600 reached 0.6–0.8 overnight at 16°C with shaking at 100 rpm. .. BL21 (DE3, TIANGEN, CB105) competent cells transformed constructs, and protein expression was induced in 3 L of bacterial culture using 0.5 mM IPTG (Sigma-Aldrich, 16758) when OD600 reached 0.6–0.8 overnight at 16°C with shaking at 100 rpm.

    Article Title: ZYG11B suppresses multiple enteroviruses by triggering viral VP1 degradation.
    Article Snippet: .. BL21 (DE3, TIANGEN, CB105) competent cells transformed constructs, and protein expression was induced in 3 L of bacterial culture using 0.5 mM IPTG (Sigma-Aldrich, 16758) when OD600 reached 0.6–0.8 overnight at 16°C with shaking at 100 rpm. ..

    Article Title: Identification and expression profiles of granzyme genes in immune response from Nile tilapia (Oreochromis niloticus)
    Article Snippet: Granzymes (Gzms) are crucial cytotoxic molecules involved in cell-mediated immunity in mammals.. However, their roles in teleost fish, such as Nile tilapia, were less understood.. In this study, we focused on the identification of granzyme genes (OnGzms) from Nile tilapia (Oreochromis niloticus) and the potential functions in antiinfectious immunity, as well as their expression patterns in response to interleukin-2 stimulation.

    other:


    Recombinant:

    Article Title: Identification and expression profiles of granzyme genes in immune response from Nile tilapia (Oreochromis niloticus)
    Article Snippet: Granzymes (Gzms) are crucial cytotoxic molecules involved in cell-mediated immunity in mammals.. However, their roles in teleost fish, such as Nile tilapia, were less understood.. In this study, we focused on the identification of granzyme genes (OnGzms) from Nile tilapia (Oreochromis niloticus) and the potential functions in antiinfectious immunity, as well as their expression patterns in response to interleukin-2 stimulation.



    Similar Products

    96
    New England Biolabs competent e coli bl21 cells
    Competent E Coli Bl21 Cells, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21+Competent+E%2E+coli/bio_rxiv__64898__2026__11__03__764021-51-0-5
    Average 96 stars, based on 1 article reviews
    competent e coli bl21 cells - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Cytiva Europe e coli strain bl21
    E Coli Strain Bl21, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/E%2E+coli+BL21/bio_rxiv__64898__2026__10__30__761943-252-15-24
    Average 96 stars, based on 1 article reviews
    e coli strain bl21 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    99
    New England Biolabs e coli strain bl21 de3
    E Coli Strain Bl21 De3, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)+Competent+E%2E+coli/pm42790276-47-17-22
    Average 99 stars, based on 1 article reviews
    e coli strain bl21 de3 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    tiangen biotech co bl21 de3
    Bl21 De3, supplied by tiangen biotech co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)/pm42956452-44-5-9
    Average 99 stars, based on 1 article reviews
    bl21 de3 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    New England Biolabs bl21 de3
    Bl21 De3, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)+Competent+E%2E+coli/bio_rxiv__64898__2026__10__31__763323-150-15-17
    Average 99 stars, based on 1 article reviews
    bl21 de3 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    93
    Addgene inc escherichia coli bl21 de3 codonplus cells
    (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of <t>α-Syn</t> PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).
    Escherichia Coli Bl21 De3 Codonplus Cells, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/human+Alpha-synuclein+(Plasmid+%2351437)/bio_rxiv__64898__2026__11__02__763615-391-10-28
    Average 93 stars, based on 1 article reviews
    escherichia coli bl21 de3 codonplus cells - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    99
    New England Biolabs bl21 de3 cells
    (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of <t>α-Syn</t> PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).
    Bl21 De3 Cells, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)+Competent+E%2E+coli/bio_rxiv__64898__2026__10__30__763152-263-4-7
    Average 99 stars, based on 1 article reviews
    bl21 de3 cells - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    New England Biolabs bl21 competent escherichia coli cells
    (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of <t>α-Syn</t> PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).
    Bl21 Competent Escherichia Coli Cells, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21+Competent+E%2E+coli/bio_rxiv__64898__2026__10__28__762535-296-9-14
    Average 96 stars, based on 1 article reviews
    bl21 competent escherichia coli cells - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    99
    tiangen biotech co e coli bl21 de3 cells
    (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of <t>α-Syn</t> PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).
    E Coli Bl21 De3 Cells, supplied by tiangen biotech co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)/pm42965742-51-17-21
    Average 99 stars, based on 1 article reviews
    e coli bl21 de3 cells - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of α-Syn PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of α-Syn PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: Control, Immunofluorescence, Fluorescence, Flow Cytometry, Western Blot, Inhibition, Staining, Synthesized

    (A) chematic overview of the experimental workflow to assess the effects of protein synthesis inhibition with cycloheximide (CHX, 50 µg/ml) on α-Syn PFF clearance. (B) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs treatment with CHX in the presence or absence of LPS. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (C) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.0001 = ****. n=4. (D) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following the indicated treatments and 3 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowheads point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (E) Quantification of α-Syn PFF uptake (left panel) and degradation (right panel) in primary microglia under the indicated treatment conditions. Degradation was expressed as a percentage of the uptake measurement. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple-comparisons test. p<.01 = **. n=3, N=6. (F) Schematic overview (left panel) of the experimental workflow to assess the effects of proteostatic stress induced by L-azetidine-2-carboxylic acid (AZC, 1 mM), a proline analogue that promotes protein misfolding and aggregation. Representative image (right panel) of protein aggregation using ProteoStat dye (red) and DAPI (blue). Scale bar: 20 µm. (G) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 h treatment with LPS or AZC. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). n=3, N=9 fields of view. p<.0001 = ****. Scale bar, 20 µm. (H) Quantification of uptake (right panel) and degradation (left panel) of α-Syn PFFs by primary microglia. Degradation is presented as percentage to uptake p<.001 = ***, p<.0001 = ****. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (B, E, G, H) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (D).

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: (A) chematic overview of the experimental workflow to assess the effects of protein synthesis inhibition with cycloheximide (CHX, 50 µg/ml) on α-Syn PFF clearance. (B) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs treatment with CHX in the presence or absence of LPS. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (C) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.0001 = ****. n=4. (D) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following the indicated treatments and 3 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowheads point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (E) Quantification of α-Syn PFF uptake (left panel) and degradation (right panel) in primary microglia under the indicated treatment conditions. Degradation was expressed as a percentage of the uptake measurement. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple-comparisons test. p<.01 = **. n=3, N=6. (F) Schematic overview (left panel) of the experimental workflow to assess the effects of proteostatic stress induced by L-azetidine-2-carboxylic acid (AZC, 1 mM), a proline analogue that promotes protein misfolding and aggregation. Representative image (right panel) of protein aggregation using ProteoStat dye (red) and DAPI (blue). Scale bar: 20 µm. (G) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 h treatment with LPS or AZC. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). n=3, N=9 fields of view. p<.0001 = ****. Scale bar, 20 µm. (H) Quantification of uptake (right panel) and degradation (left panel) of α-Syn PFFs by primary microglia. Degradation is presented as percentage to uptake p<.001 = ***, p<.0001 = ****. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (B, E, G, H) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (D).

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: Inhibition, Immunofluorescence, Staining, Western Blot, Synthesized

    (A) Schematic overview of the canonical autophagy pathway and endolysosomal pathway. (B) Representative Western blot (left panel) and quantification (right panel) of autophagic flux assessed by LC3B-II accumulation in the presence or absence of bafilomycin A1 (BafA1, 100 nM, 4 hrs). LC3B-II protein levels were normalized to β-actin. n=7. (C) Representative Western blot (left panel) and quantification (right panel) of p62 protein levels in primary microglia following 24 hrs α-Syn PFF uptake and subsequent degradation for 24-72 h. p62 levels were normalized to β-actin. n=3. p<.05 = *. (D) Proteomics-derived module scores of the GO pathway “Late endosome to lysosome maturation” (upper panel) and “HOPS complex” (lower panel) under the indicated treatment conditions. p<.05 = *, p<.01 = **, p<.001 = ***, p<.0001 = ****. n=8. (E) Representative immunofluorescence images showing the subcellular localization of α-Syn PFFs (red), Rab7 (yellow), and cathepsin D (CatD, green) in primary microglia. Nuclei were counterstained with DAPI (blue). Three-dimensional reconstructions illustrate the spatial association of α-Syn PFFs with Rab7- and CatD-positive compartments, as indicated by arrowheads. Scale bar: 10 µm. (F) Representative immunofluorescence images (upper panel) of primary microglia following 24 hrs α-Syn PFF uptake (grey) in the presence or absence of LPS (10 ng/ml). Cells were stained for CatD (red) and F-actin (green). Fluorescence intensity profiles (lower panel) along the indicated lines show reduced colocalization of α-Syn PFFs with CatD-positive compartments following LPS treatment. Scale bars: 50 µm. (G) Quantification of α-Syn PFF puncta lacking CatD colocalization (free α-Syn puncta), expressed as absolute values and as a percentage of total α-Syn-positive area per cell. Measurements were performed following 24 hrs uptake (upper panel) and an additional 24 hrs degradation (lower panel) period under the indicated treatment conditions. p<.01 = **, p<.0001 = ****. n=3, N=104-199. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by t-test (G), one-way ANOVA followed by Tukey’s test (B, C) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (D).

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: (A) Schematic overview of the canonical autophagy pathway and endolysosomal pathway. (B) Representative Western blot (left panel) and quantification (right panel) of autophagic flux assessed by LC3B-II accumulation in the presence or absence of bafilomycin A1 (BafA1, 100 nM, 4 hrs). LC3B-II protein levels were normalized to β-actin. n=7. (C) Representative Western blot (left panel) and quantification (right panel) of p62 protein levels in primary microglia following 24 hrs α-Syn PFF uptake and subsequent degradation for 24-72 h. p62 levels were normalized to β-actin. n=3. p<.05 = *. (D) Proteomics-derived module scores of the GO pathway “Late endosome to lysosome maturation” (upper panel) and “HOPS complex” (lower panel) under the indicated treatment conditions. p<.05 = *, p<.01 = **, p<.001 = ***, p<.0001 = ****. n=8. (E) Representative immunofluorescence images showing the subcellular localization of α-Syn PFFs (red), Rab7 (yellow), and cathepsin D (CatD, green) in primary microglia. Nuclei were counterstained with DAPI (blue). Three-dimensional reconstructions illustrate the spatial association of α-Syn PFFs with Rab7- and CatD-positive compartments, as indicated by arrowheads. Scale bar: 10 µm. (F) Representative immunofluorescence images (upper panel) of primary microglia following 24 hrs α-Syn PFF uptake (grey) in the presence or absence of LPS (10 ng/ml). Cells were stained for CatD (red) and F-actin (green). Fluorescence intensity profiles (lower panel) along the indicated lines show reduced colocalization of α-Syn PFFs with CatD-positive compartments following LPS treatment. Scale bars: 50 µm. (G) Quantification of α-Syn PFF puncta lacking CatD colocalization (free α-Syn puncta), expressed as absolute values and as a percentage of total α-Syn-positive area per cell. Measurements were performed following 24 hrs uptake (upper panel) and an additional 24 hrs degradation (lower panel) period under the indicated treatment conditions. p<.01 = **, p<.0001 = ****. n=3, N=104-199. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by t-test (G), one-way ANOVA followed by Tukey’s test (B, C) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (D).

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: Western Blot, Proteomic Assay, Derivative Assay, Immunofluorescence, Staining, Fluorescence

    (A) Heatmap showing Z-score-normalized protein abundance of all proteins associated with the GO term “Lysosome” under the indicated treatment conditions. (B) Representative Western blot (left panel) and quantification (right panel) of CatD protein levels in primary microglia under the indicated treatment conditions. CatD levels were normalized to β-actin. Cropped regions of the Western blot are indicated by dashed lines. p<.05 = *, p<.01 = **. n=4. (C) Proteomics-derived TFEB protein abundance under the indicated treatment conditions, expressed as Z-scores. p<.01 = **. (D) Schematic overview of the experimental workflow to assess the effects of pharmacological TFEB activation on α-Syn PFF clearance. (E) Quantification of uptake (left panel) and degradation after 24 hrs (middle panel) and 48 hrs (right panel) of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. p<.01 = **, p<.0001 = ****. (F, G) Representative immunofluorescence images (right panel)) and quantification (left panel) of CatD-positive structures in primary microglia under the indicated treatment conditions. p<.01 = **, p<.001 = ***, p<.0001 = ****. n=3, N=34-118 (uptake) and N=17-125. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (B, E (uptake data)) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (C, E (degradation data), F, G).

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: (A) Heatmap showing Z-score-normalized protein abundance of all proteins associated with the GO term “Lysosome” under the indicated treatment conditions. (B) Representative Western blot (left panel) and quantification (right panel) of CatD protein levels in primary microglia under the indicated treatment conditions. CatD levels were normalized to β-actin. Cropped regions of the Western blot are indicated by dashed lines. p<.05 = *, p<.01 = **. n=4. (C) Proteomics-derived TFEB protein abundance under the indicated treatment conditions, expressed as Z-scores. p<.01 = **. (D) Schematic overview of the experimental workflow to assess the effects of pharmacological TFEB activation on α-Syn PFF clearance. (E) Quantification of uptake (left panel) and degradation after 24 hrs (middle panel) and 48 hrs (right panel) of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. p<.01 = **, p<.0001 = ****. (F, G) Representative immunofluorescence images (right panel)) and quantification (left panel) of CatD-positive structures in primary microglia under the indicated treatment conditions. p<.01 = **, p<.001 = ***, p<.0001 = ****. n=3, N=34-118 (uptake) and N=17-125. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (B, E (uptake data)) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (C, E (degradation data), F, G).

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: Quantitative Proteomics, Western Blot, Proteomic Assay, Derivative Assay, Activation Assay, Immunofluorescence

    (A) Reanalysis of publicly available RNA-seq data from human brain-derived microglia (GSE249315; Snijders et al., 2023) comparing LPS-stimulated and unstimulated cells. Transcriptional changes in the indicated biological processes are expressed as Cohen’s d (LPS vs. unstimulated) with 95% confidence intervals (CI). p<.01 = **, p<.001 = ***. (B) eanalysis of published proteomics data from human iPSC-derived microglia (Hellén et al., 2025) comparing LPS/IFNγ-stimulated and unstimulated cells. Changes in protein abundance are expressed as log2 fold change relative to unstimulated controls.p<.01 = **, p<.001 = ***. (C) Schematic overview (left panel) and representative immunofluorescence images (middel panel) of the engraftment of human iPSC-derived microglial precursors (iMic) into organotypic brain slice cultures. Cultures were treated with α-Syn (2 µM) and LPS (200 ng/ml) and stained for microglia (Iba1, white), α-Syn (green), CatD (red), and DAPI (blue). Fluorescence intensity profiles (left panel) illustrate the limited overlap of α-Syn and CatD signals. Scale bar, 30 µm. (D-E) Representative immunofluorescence images of post-mortem human brain tissue from neurologically healthy controls. Sections were stained for microglia (Iba1, white), phosphorylated α-Syn pSer129 (green), CatD (red), and DAPI (blue). Scale bar, 30 µm. (F-G) Representative immunofluorescence images (left panel) of post-mortem human brain tissue from patients with dementia with Lewy bodies (DLB, Braak stage 6). Sections were stained for Iba1 (white), α-Syn pSer129 (green), CatD (red), and DAPI (blue). Fluorescence intensity profiles (right panel) illustrate limited colocalization of pathological α-Syn with CatD-positive compartments. Scale bar, 30 µm. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as horizontal dot plot of module median Cohen’s d and log2 fold changes and were analyzed by paired t-test (A) and Fisher’s combined p-value (B).

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: (A) Reanalysis of publicly available RNA-seq data from human brain-derived microglia (GSE249315; Snijders et al., 2023) comparing LPS-stimulated and unstimulated cells. Transcriptional changes in the indicated biological processes are expressed as Cohen’s d (LPS vs. unstimulated) with 95% confidence intervals (CI). p<.01 = **, p<.001 = ***. (B) eanalysis of published proteomics data from human iPSC-derived microglia (Hellén et al., 2025) comparing LPS/IFNγ-stimulated and unstimulated cells. Changes in protein abundance are expressed as log2 fold change relative to unstimulated controls.p<.01 = **, p<.001 = ***. (C) Schematic overview (left panel) and representative immunofluorescence images (middel panel) of the engraftment of human iPSC-derived microglial precursors (iMic) into organotypic brain slice cultures. Cultures were treated with α-Syn (2 µM) and LPS (200 ng/ml) and stained for microglia (Iba1, white), α-Syn (green), CatD (red), and DAPI (blue). Fluorescence intensity profiles (left panel) illustrate the limited overlap of α-Syn and CatD signals. Scale bar, 30 µm. (D-E) Representative immunofluorescence images of post-mortem human brain tissue from neurologically healthy controls. Sections were stained for microglia (Iba1, white), phosphorylated α-Syn pSer129 (green), CatD (red), and DAPI (blue). Scale bar, 30 µm. (F-G) Representative immunofluorescence images (left panel) of post-mortem human brain tissue from patients with dementia with Lewy bodies (DLB, Braak stage 6). Sections were stained for Iba1 (white), α-Syn pSer129 (green), CatD (red), and DAPI (blue). Fluorescence intensity profiles (right panel) illustrate limited colocalization of pathological α-Syn with CatD-positive compartments. Scale bar, 30 µm. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as horizontal dot plot of module median Cohen’s d and log2 fold changes and were analyzed by paired t-test (A) and Fisher’s combined p-value (B).

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: RNA Sequencing, Derivative Assay, Proteomic Assay, Quantitative Proteomics, Immunofluorescence, Slice Preparation, Staining, Fluorescence, Tissue, IPSC

    LPS-mediated activation of TLR4 increases protein synthesis and thereby elevates intracellular proteostatic burden in microglia. Although canonical autophagic flux remains largely preserved, lysosomal adaptation becomes insufficient to meet this increased demand. As a result, aggregate-containing endolysosomal cargo shows impaired progression toward mature CatD-positive degradative compartments, leading to reduced clearance of extracellular α-Syn aggregates. Proteostatic stress induced independently of TLR4 signaling is sufficient to phenocopy the α-Syn degradation defect, whereas increasing lysosomal capacity through TFEB activation restores aggregate clearance.

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: LPS-mediated activation of TLR4 increases protein synthesis and thereby elevates intracellular proteostatic burden in microglia. Although canonical autophagic flux remains largely preserved, lysosomal adaptation becomes insufficient to meet this increased demand. As a result, aggregate-containing endolysosomal cargo shows impaired progression toward mature CatD-positive degradative compartments, leading to reduced clearance of extracellular α-Syn aggregates. Proteostatic stress induced independently of TLR4 signaling is sufficient to phenocopy the α-Syn degradation defect, whereas increasing lysosomal capacity through TFEB activation restores aggregate clearance.

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: Activation Assay